Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Novavax Inc. is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 2 distinct art units, indicating a focused but divided technical scope. The portfolio is handled by 4 distinct examiners, meaning each of the pending office actions is assigned to a different person.
FOLEY, SHANON A is the busiest examiner for the portfolio with 1 pending case. Since no single examiner manages more than one action, the company's prosecution results depend on independent evaluations. Practitioners must navigate the specific requirements of 2 distinct art units while addressing the individual feedback from each of the examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.3% | +18.1% |
| DUFFY, PATRICIA ANN | 1 | 52.9% | +33.9% |
| CHEONG, CHEOM-GIL | 1 | 64.2% | +52.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18712227 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA | DUFFY, PATRICIA ANN | — |
| 18704632 | MALARIA VACCINE FORMULATIONS | CHEONG, CHEOM-GIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18828852 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE | FOLEY, SHANON A | — |
| 18712227 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA | DUFFY, PATRICIA ANN | — |
| 18704632 | MALARIA VACCINE FORMULATIONS | CHEONG, CHEOM-GIL | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18828852 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE | FOLEY, SHANON A | — | Other | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18712227 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA | DUFFY, PATRICIA ANN | 1645 | §103§112 | Non-Final OA | — | Pending | May 21, 2024 |
| 18704632 | MALARIA VACCINE FORMULATIONS | CHEONG, CHEOM-GIL | — | §102§103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial